Date

May 18, 2021

Time

10:00 AM – 11:00 AM CDT

Category

Therapeutic Innovation

Location

Online

Webinar: HLA Peptide Target Discovery – Mitigating Risk in Target Selection

In this webinar, members of the Pure MHC research team will present and discuss data and learnings drawn from decades of experience identifying and validating HLA peptide targets for therapeutic development. Special emphasis will be given to mitigating risk in preclinical target selection for oncology and infectious disease indications.

 

Participation is free, however registration is required before May 18, 2021

Program:

10:00 Introductions

  • Target Discovery in Infectious Disease: West Nile Virus Case Study
  • Oncology Therapeutic Proof of Concept: Melanoma Case Study
  • Tools for Receptor Validation
  • Ovarian Cancer Oncology Case Study
  • Summary of Risk Mitigation Through Pure MHC Target Discovery Methods

10:50 Q & A

 

Complete the form below and click “Register Now” to save your seat:

Presenters